Skip to main content

Brian T Crouch

Assistant Research Professor in the Department of Biomedical Engineering
Biomedical Engineering
Room 1427 FCIEMAS, Box 90281, Durham, NC 27708
140 Science Drive, 373 Gross Hall, Durham, NC 27708

Overview


Dr. Crouch is an Assistant Research Professor in the Department of Biomedical Engineering and the Assistant Director of Research for the Center for Global Women's Health Technologies (GWHT). Dr. Crouch’s research interests intersect oncology, translational research, and global health, with a particular focus on diagnostics and therapeutics in low-resource settings. He is an expert in translating diagnostic technologies from the bench to bedside using in vitro cell culture and cell-based assays, small animal models, fluorescence microscopy, image processing, machine learning, and clinical trial design.

Current Appointments & Affiliations


Assistant Research Professor in the Department of Biomedical Engineering · 2020 - Present Biomedical Engineering, Pratt School of Engineering
Member of the Duke Cancer Institute · 2025 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published January 22, 2025
From Philosophy to the U.S. Court of Appeals, Duke Authors Cover Big Topics

View All News

Recent Publications


Biomedical Engineering for Global Health

Journal Article · November 21, 2024 Explore the fundamentals of biomedical engineering technologies with this thought-provoking introduction, framed around modern-day global cancer inequities. Connecting engineering principles to real-world global health scenarios, this textbook intr ... Full text Cite

Impact of Injection-Based Delivery Parameters on Local Distribution Volume of Ethyl-Cellulose Ethanol Gel in Tissue and Tissue Mimicking Phantoms.

Journal Article IEEE transactions on bio-medical engineering · May 2024 ObjectiveLocal drug delivery aims to minimize systemic toxicity by preventing off-target effects; however, injection parameters influencing depot formation of injectable gels have yet to be thoroughly studied. We explored the effects of needle cha ... Full text Cite

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence.

Journal Article Sci Adv · April 5, 2024 Fewer than 20% of triple-negative breast cancer patients experience long-term responses to mainstay chemotherapy. Resistant tumor subpopulations use alternative metabolic pathways to escape therapy, survive, and eventually recur. Here, we show in vivo, lon ... Full text Link to item Cite
View All Publications

Recent Grants


A single shot therapy will accelerate the elimination of breast cancer

ResearchCollaborating Investigator · Awarded by United States Army Medical Research Acquisition Activity · 2024 - 2028

View All Grants

Education, Training & Certifications


Duke University · 2018 Ph.D.